LINC01020

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, LINC01020 mutation is significantly associated with the immune_cell of many other genes, with 2 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible LINC01020-associated genes across cancer lineages are Mast cells and Myocytes. Each is linked with LINC01020 in more than 1 cancer types. Because this analysis shows association rather than direction, both LINC01020-to-partner and partner-to-LINC01020 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (LINC01020→partner) and Y-score (partner→LINC01020) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECMast cells →+0.021+2.212.010.03431
UCECMyocytes →+0.057+3.016<.001.01921
Each partner links to its Q-omics profile. Showing the 2 strongest of 2 associations by consensus.

Exploration